Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Moving iMage Technologies
MITQ
$5.44M
| $65K | ﹤0.01% |
49,800
-69,051
| -58% | -$81.6K |
|
|
FWP
3952
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $65K | ﹤0.01% |
14,500
-10,000
| -41% | -$53.2K |
|
|
PTN
3953
Palatin Technologies
PTN
$16.8M
| $64K | ﹤0.01% |
182
+145
| +392% | +$66.9K |
|
3954
SiriusXM
SIRI
$9.59B
| $64K | ﹤0.01% |
+1,040
| New | +$64.6K |
|
3955
IZEA Worldwide
IZEA
$53.8M
| $63K | ﹤0.01% |
17,450
-48,200
| -73% | -$207K |
|
|
MDRR
3956
Medalist Diversified Inc
MDRR
| $63K | ﹤0.01% |
4,750
+900
| +23% | +$14.3K |
|
3957
Neuropace
NPCE
$496M
| $63K | ﹤0.01% |
+12,700
| New | +$83.9K |
|
3958
SOPHiA GENETICS
SOPH
$635M
| $63K | ﹤0.01% |
+17,500
| New | +$88.8K |
|
|
SYBX
3959
DELISTED
Synlogic
SYBX
| $63K | ﹤0.01% |
3,667
+247
| +7% | +$5.34K |
|
|
PTE
3960
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $63K | ﹤0.01% |
43,322
+39,042
| +912% | +$141K |
|
|
CFRX
3961
DELISTED
ContraFect Corporation
CFRX
| $63K | ﹤0.01% |
+258
| New | +$72.9K |
|
|
ASPU
3962
DELISTED
ASPEN GROUP, INC.
ASPU
| $62K | ﹤0.01% |
63,277
+52,177
| +470% | +$50.8K |
|
|
OKUR
3963
OnKure Therapeutics
OKUR
$159M
| $61K | ﹤0.01% |
+2,300
| New | +$53.5K |
|
|
ZENV
3964
DELISTED
Zenvia
ZENV
| $60K | ﹤0.01% |
28,300
+12,600
| +80% | +$60.3K |
|
|
BLRX
3965
BioLineRX
BLRX
$11.7M
| $59K | ﹤0.01% |
1,144
-540
| -32% | -$30K |
|
|
CPAC
3966
Cementos Pacasmayo
CPAC
$1.02B
| $59K | ﹤0.01% |
+12,464
| New | +$69.9K |
|
|
FORA
3967
DELISTED
Forian
FORA
| $59K | ﹤0.01% |
+13,500
| New | +$52K |
|
|
SANW
3968
DELISTED
S&W Seed Co
SANW
| $59K | ﹤0.01% |
3,117
+137
| +5% | +$3.57K |
|
3969
Tempest Therapeutics
TPST
$19.3M
| $59K | ﹤0.01% |
2,100
-992
| -32% | -$38.6K |
|
|
ATHX
3970
DELISTED
Athersys, Inc. Common Stock
ATHX
| $59K | ﹤0.01% |
9,116
-6,083
| -40% | -$67.3K |
|
|
CNTB
3971
Connect Biopharma Holdings
CNTB
$147M
| $58K | ﹤0.01% |
66,900
+43,400
| +185% | +$63.9K |
|
3972
Jiuzi Holdings
JZXN
$738K
| $58K | ﹤0.01% |
7
+2
| +40% | +$21.1K |
|
3973
NovaGold Resources
NG
$3.45B
| $58K | ﹤0.01% |
12,100
-603,600
| -98% | -$3.77M |
|
|
RGLS
3974
DELISTED
Regulus Therapeutics
RGLS
| $58K | ﹤0.01% |
28,100
+14,760
| +111% | +$35.8K |
|
3975
Rezolute
RZLT
$453M
| $58K | ﹤0.01% |
+17,900
| New | +$59.5K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.